+44-20-4587-4809Immunome Research : Citations & Metrics Report
Articles published in Immunome Research have been cited by esteemed scholars and scientists all around the world. Immunome Research has got h-index 15, which means every article in Immunome Research has got 15 average citations.
Following are the list of articles that have cited the articles published in Immunome Research.
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Year wise published articles |
40 | 13 | 7 | 20 |
Year wise citations received |
111 | 109 | 84 | 74 |
| Journal total citations count | 817 |
| Journal impact factor | 9.00 |
| Journal 5 years impact factor | 10.13 |
| Journal cite score | 13.75 |
| Journal h-index | 15 |
| Journal h-index since 2018 | 13 |
Important citations (1540)
Misso g, gatta ng, zarone mr, cammarota g, grimaldi a, gentile v. possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. translational medicine reports. 2017 jul 19;1(2). |
|
Zimon rl, lerman g, elharrar e, meningher t, barzilai a, masalha m, chintakunta r, hollander e, goldbart r, traitel t, harats m. ultrasound targeting of q-starch/mir-197 complexes for topical treatment of psoriasis. journal of controlled release. 2018 aug 28;284:103-11. |
|
Gatta ng, romano r, fioretti e, gentile v. transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders. aims molecular science. 2017;4(4):399-414. |
|
Lerner a, benzvi c. “let food be thy medicine”: gluten and potential role in neurodegeneration. cells. 2021 apr;10(4):756. |
|
Masalha m, sidi y, avni d. the contribution of feedback loops between mirnas, cytokines and growth factors to the pathogenesis of psoriasis. experimental dermatology. 2018 jun;27(6):603-10. |
|
Lawrence p, ceccoli j. advances in the application and impact of micrornas as therapies for skin disease. biodrugs. 2017 oct;31(5):423-38. |
|
Lerner a, ramesh a, matthias t. the temperature and ph repertoire of the transglutaminase family is expanding. febs open bio. 2020 apr;10(4):492-4. |
|
Pourmohammadi k, abedi e. enzymatic modifications of gluten protein: oxidative enzymes. food chemistry. 2021 mar 26;356:129679-. |
|
Lerner a, matthias t. processed food additive microbial transglutaminase and its cross-linked gliadin complexes are potential public health concerns in celiac disease. international journal of molecular sciences. 2020 jan;21(3):1127. |
|
Lerner a, matthias t. processed food additive microbial transglutaminase and its cross-linked gliadin complexes are potential public health concerns in celiac disease. international journal of molecular sciences. 2020 jan;21(3):1127. |
|
Gatta ng, cammarota g, gentile v. possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases. aims biophysics. 2016;3(4):529-45. |
|
Lerner a, neidhöfer s, matthias t. anti-ttg-iga is neither a solved problem nor a “closed case” in celiac disease diagnosis. int j celiac dis. 2017;5:97-100. |
|
Agardh d, matthias t, wusterhausen p, neidhöfer s, heller a, lerner a. antibodies against neo?epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease. clinical & experimental immunology. 2020 mar;199(3):294-302. |
|
Lerner a, matthias t. gut-bone cross talks and implications in celiac disease. int j celiac dis. 2016;4(1):19-23. |
|
Lerner a, jeremias p, neidhöfer s, matthias t. comparison of the reliability of 17 celiac disease associated bio-markers to reflect intestinal damage. j clin cell immunol. 2017;8(486):2. |
|
Lerner a, ramesh a, matthias t. serologic diagnosis of celiac disease: new biomarkers. gastroenterology clinics. 2019 jun 1;48(2):307-17. |
|
Lerner a, matthias t. don’t forget the exogenous microbial transglutaminases: it is immunogenic and potentially pathogenic. aims biophysics. 2016 jan 1;3(4):546-52. |
|
Lerner a, ramesh a, matthias t. are non-celiac autoimmune diseases responsive to gluten-free diet. int j celiac dis. 2017;5:164-7. |
|
Lerner a, matthias t. microbial transglutaminase is beneficial to food industries but a caveat to public health. med one. 2019 jan 4;4(1). |
|
Narciso-schiavon jl, schiavon ll. to screen or not to screen? celiac antibodies in liver diseases. world journal of gastroenterology. 2017 feb 7;23(5):776. |
|